RT Journal Article
SR Electronic
T1 Clinical genetics lacks standard definitions and protocols for the collection and use of diversity measures
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.22.20074500
DO 10.1101/2020.04.22.20074500
A1 Popejoy, Alice B.
A1 Crooks, Kristy R.
A1 Fullerton, Stephanie M.
A1 Hindorff, Lucia A.
A1 Hooker, Gillian W.
A1 Koenig, Barbara A.
A1 Pino, Natalie
A1 Ramos, Erin M.
A1 Ritter, Deborah I.
A1 Wand, Hannah
A1 Wright, Matt W.
A1 Yudell, Michael
A1 Zou, James Y.
A1 Plon, Sharon E.
A1 Bustamante, Carlos D.
A1 Ormond, Kelly E.
A1 on behalf of the Clinical Genome Resource (ClinGen) Ancestry and Diversity Working Group (ADWG)
YR 2020
UL http://medrxiv.org/content/early/2020/04/23/2020.04.22.20074500.abstract
AB Genetics researchers and clinical professionals rely on diversity measures such as race, ethnicity, and ancestry (REA) to stratify study participants and patients for a variety of applications in research and precision medicine. However, there are no comprehensive, widely accepted standards or guidelines for collecting and using such data in either setting. Two NIH-funded research consortia, the Clinical Genome Resource (ClinGen) and Clinical Sequencing Evidence-generating Research (CSER), have partnered to address this issue and report how REA are currently collected, conceptualized, and used. Surveying clinical genetics professionals and researchers (N=448), we found heterogeneity in the way REA are perceived, defined, and measured, with variation in the perceived importance of REA in both clinical and research settings. The majority of respondents (>55%) felt that REA are at least somewhat important for clinical variant interpretation, ordering genetic tests, and communicating results to patients. However, there was no consensus on the relevance of REA, including how each of these measures should be used in different scenarios and what information they can convey in the context of human genetics. A lack of common definitions and applications of REA across the precision medicine pipeline may contribute to inconsistencies in data collection, missing or inaccurate classifications, and misleading or inconclusive results. Thus, our findings support the need for standardization and harmonization of REA data collection and use in clinical genetics and precision health research.Competing Interest StatementG.H. is an employee of Concert Genetics and a member of the Board of Directors of My Gene Counsel. S.E.P. is a member of the Scientific Advisory Board of Baylor Genetics Laboratory. C.B.D. is President and Chairman of CBD Consulting LTD and a venture partner at F-Prime Capital. None of these entities played a role in the design or interpretation of the results presented here.Funding StatementFunding for this study was provided by the National Human Genome Research Institute (NHGRI) Clinical Genome Resource (ClinGen): 5U41HG009649-03; the Clinical Sequencing Evidence-generating Research (CSER) Coordinating Center: U24HG007307; the UCSF Program in Prenatal and Pediatric Genome Sequencing (P3EGS): U01HG009599; and a Chan-Zuckerberg Investigator Award (J.Y.Z.).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData may be available upon request to the corresponding author.